Lipodystrophies Completed Phase 2 Trials for Zidovudine (DB00495)

Also known as: Lipodystrophy / Lipodystrophy NOS / Lipodystrophy acquired

IndicationStatusPhase
DBCOND0026618 (Lipodystrophies)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00021463Changing to Nonprotease Inhibitor Treatment to Improve Side EffectsTreatment